Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VIVUS Inc (NASDAQ:VVUS)

1.22
Delayed Data
As of Jun 23
 +0.06 / +5.17%
Today’s Change
0.93
Today|||52-Week Range
1.47
+6.09%
Year-to-Date
Regeneron (REGN) Stock on Fire: What's Behind the Surge?
Jun 23 / Zacks.com - Paid Partner Content
Glaxo's (GSK) Shingles Candidate Phase III Data Positive
Jun 22 / Zacks.com - Paid Partner Content
Here's Why Investors Are Glued to Vertex Pharma (VRTX) Stock
Jun 23 / Zacks.com - Paid Partner Content
Novartis Announces Positive Results for Cardiovascular Drug
Jun 22 / Zacks.com - Paid Partner Content
Shire (SHPG) Receives MAA Validation for Veyvondi by EMA
Jun 22 / Zacks.com - Paid Partner Content
BioMarin (BMRN) in Focus: Stock Moves 7% Higher
Jun 22 / Zacks.com - Paid Partner Content
Here's Why Geron (GERN) is a Good Stock to Invest in Now
Jun 22 / Zacks.com - Paid Partner Content
Myriad Genetics (MYGN) Catches Eye: Stock Moves Up 5.7%
Jun 22 / Zacks.com - Paid Partner Content
Indivor's Opioid Use Disorder Drug Meets Primary Endpoint
Jun 22 / Zacks.com - Paid Partner Content
Novartis Migraine Drug Accepted, AMD Positive in Phase III
Jun 21 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close1.16
Today’s open1.16
Day’s range1.14 - 1.24
Volume2,242,660
Average volume (3 months)776,978
Market cap$128.9M
Dividend yield--
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-277.27%
Earnings growth (next 5 years)+0.84%
Revenue growth (last year)+30.21%
P/E ratio3.7
Price/Sales0.97
Price/Book7.04

Competitors

 Today’s
change
Today’s
% change
GEMPGemphire Therapeutic...+0.84+7.43%
CRMECardiome Pharma Corp+0.02+0.50%
SBPHSpring Bank Pharmace...+0.33+2.54%
--China Health Group I...-0.01-8.70%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$124.3M
Annual profit (last year)$23.3M
Net profit margin18.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Seth H. Z. Fischer
Chief Financial &
Accounting Officer
Mark K. Oki
Corporate headquarters
Campbell, California

Forecasts